Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
KP2061
- Development stage
- Preclinical
- Lead developer
- K Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
KP2061 is a small molecule drug candidate being developed by **K Pharma, Inc.** for the treatment of **hearing loss**, specifically sensorineural hearing loss. It is a **drug repositioning** asset, utilizing a **phosphodiesterase 5 (PDE5) inhibitor** that was previously identified or approved for other therapeutic indications. The development of KP2061 is a collaborative effort with **Kitasato University**, building on research by Professor Kohichiro Shigeno which suggests that PDE5 inhibition can enhance cochlear blood flow and provide neuroprotective effects in the auditory system. As of 2024, the program is in the **preclinical** stage, with K Pharma having secured specific compound patents and conducting final evaluations to support its transition into clinical development.
- Other names
- KP2061KP-2061KP 2061
02
Targets
PDE5 (Phosphodiesterase 5A)
Beyond the preview
Go deeper on KP2061.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KP2061.